Drugs / OTC Drug for Atopic Dermatitis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07146971 | Aug 2025 → May 2026 | atopic eczema | Good Molecules, LLC | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OTC Drug for Atopic Dermatitis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07146971 ↗ |